@article{oai:niigata-u.repo.nii.ac.jp:00019950,
 author = {青木, 信樹},
 issue = {8},
 journal = {新潟医学会雑誌, 新潟医学会雑誌},
 month = {Aug},
 note = {Clinical studies were performed in 508 cases with respiratory tract infections, from 1990 through 1991, at Shinrakuen Hospital. These cases consited of 255 pneumonias, 6 pulmonary abscesses, 222 secondary infections to chronic respiratory tract diseases, 11 pyothoraxes and 14 other infections. Causative organisms were unknown in 48.7% of the patients with pneumonia or pulmonary abscess, gram-positive cocci were isolated in 19.2% of them, gram-negative rods in 14.2%, and mixed infections in 15.3%. S.aureus was isolated in 23 patients （MRSA 14, MSSA 9 cases）, and that （8.8%） was the most frequent organism causing pneumonia or pulmonary abscess. In chronic respiratory tract infections, gram-negative pathogens were dominant in causative organisms （35.1%）, gram-positive cocci in 14.4%, mixed infections in 14.0%, and unknown in 36.5%. Major six organisms were P.aeruginosa （10.8%）, S.pneumoniae （8.1%）, S.aureus （5.9%）, H.influenzae （5.9%）, Haemophilus sp. （5.9%） and B.catarrhalis （4.1%）. The mortality in pneumonia or pulmonary abscess with MRSA infection was 40.0% and that in chronic respiratory tract infection was 30.8%. The over all clinical effect was good in 25 patients （53.4%） poor in 21 with MRSA infection on pneumonia or pulmonary abscess. Bacteriologically, MRSA was eradicated in 8 patients （17.4%）, decreased in 6, and unchanged in 32. From this study, β-lactam antibiotic combined with ABK or VCM was considered to be useful in the treatment of MRSA infection in respiratory tract.},
 pages = {687--695},
 title = {2）-②MRSA呼吸器感染症(シンポジウム MRSA感染, 現状と対策, 第480回新潟医学会)},
 volume = {107},
 year = {1993}
}